Related references
Note: Only part of the references are listed.Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans
Fumiyuki Otsuka et al.
CIRCULATION (2014)
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Giovanna Sarno et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
The REMEDEE Trial A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent
Michael Haude et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
In vivo biocompatibility of a plasma-activated, coronary stent coating
Anna Waterhouse et al.
BIOMATERIALS (2012)
Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model
Katarina Larsen et al.
EUROPEAN HEART JOURNAL (2012)
Lower risk of stent thrombosis and restenosis with unrestricted use of onew-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Giovanna Sarno et al.
EUROPEAN HEART JOURNAL (2012)
Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system
Erica Locatelli et al.
JOURNAL OF NANOPARTICLE RESEARCH (2012)
Plasma-Modified and Polyethylene Glycol-Grafted Polymers for Potential Tissue Engineering Applications
V. Svorcik et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2012)
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction The MASTER Trial
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Plasma-based biofunctionalization of vascular implants
Steven G. Wise et al.
NANOMEDICINE (2012)
Surface Modification of Biomaterials: A Quest for Blood Compatibility
Achala de Mel et al.
INTERNATIONAL JOURNAL OF BIOMATERIALS (2012)
Bioresorbable Scaffold Technologies
Yosinobu Onuma et al.
CIRCULATION JOURNAL (2011)
Intravascular Ultrasound Results From the NEVO ResElution-I Trial A Randomized, Blinded Comparison of Sirolimus-Eluting NEVO Stents With Paclitaxel-Eluting Taxus Liberte Stents in De Novo Native Coronary Artery Lesions
Hiromasa Otake et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Comparison of Everolimus- and Paclitaxel-Eluting Stents in Patients With Acute and Stable Coronary Syndromes Pooled Results From the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials
David Planer et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Nanomedicine for oral chemotherapy
Si-Shen Feng et al.
NANOMEDICINE (2011)
Free radical functionalization of surfaces to prevent adverse responses to biomedical devices
Marcela M. M. Bilek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Novel fully bioabsorbable salicylate-based sirolimus-eluting stent
Refat Jabara et al.
EuroIntervention (2011)
In vitro and in vivo performance of a dual drug-eluting stent (DDES)
Yingying Huang et al.
BIOMATERIALS (2010)
The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents
Anna Waterhouse et al.
BIOMATERIALS (2010)
Bioresorbable Stents The Next Revolution
John A. Bittl
CIRCULATION (2010)
Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial A Randomized, Multicenter Comparison of the NEVO Sirolimus-Eluting Coronary Stent With the TAXUS Liberte Paclitaxel-Eluting Stent in De Novo Native Coronary Artery Lesions
John A. Ormiston et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
New Drug-Eluting Stents An Overview on Biodegradable and Polymer-Free Next-Generation Stent Systems
Alexandre Abizaid et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
Marcel A. M. Beijk et al.
EUROPEAN HEART JOURNAL (2010)
Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?
Scot Garg et al.
EUROPEAN HEART JOURNAL (2010)
Long-term follow-up of patients with sirolimus-eluting stents for treatment of bare-metal in-stent restenosis
Claude Le Feuvre et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
A Novel Paclitaxel-Eluting Stent With an Ultrathin Abluminal Biodegradable Polymer 9-Month Outcomes With the JACTAX HD Stent
Eberhard Grube et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Elvin Kedhi et al.
LANCET (2010)
The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: A review
Barry O'Brien et al.
ACTA BIOMATERIALIA (2009)
Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial
Gregg W. Stone et al.
CIRCULATION (2009)
Bioabsorbable Coronary Stents
John A. Ormiston et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Evaluation of Drug-Eluting Stents' Coating Durability-Clinical and Regulatory Implications
Yair Levy et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2009)
Passive and Active Polymer Coatings for Intracoronary Stents: Novel Devices to Promote Arterial Healing
Lakshmana Pendyala et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2009)
Acetylene plasma polymerized surfaces for covalent immobilization of dense bioactive protein monolayers
Yongbai Yin et al.
SURFACE & COATINGS TECHNOLOGY (2009)
Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy
Mounir W. Z. Basalus et al.
EUROINTERVENTION (2009)
Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data)
Gregg W. Stone et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Stent thrombosis in 2008: Definition, predictors, prognosis and treatment
Gilles Lemesle et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2008)
Biofunctionalization of Biomaterials for Accelerated in Situ Endothelialization: A Review
Achala de Mel et al.
BIOMACROMOLECULES (2008)
Patterns of coronary heart disease mortality over the 20th century in England and Wales:: Possible plateaus in the rate of decline
Steven Allender et al.
BMC PUBLIC HEALTH (2008)
Endothelial cell recovery between comparator polymer-based drug-eluting stents
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker et al.
LANCET (2008)
Vascular responses to drug eluting stents - Importance of delayed healing
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents:: a prospective, non-randomised multicentre trial
Raimund Erbel et al.
LANCET (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Role of clopidogrel in managing atherothrombotic cardiovascular disease
Shervin Eshaghian et al.
ANNALS OF INTERNAL MEDICINE (2007)
Drug-eluting stent and coronary thrombosis -: Biological mechanisms and clinical implications
Thomas F. Luescher et al.
CIRCULATION (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation - Impact on restenosis
Teruo Inoue et al.
CIRCULATION (2007)
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
Eric L. Eisenstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Coronary stents: A materials perspective
Gopinath Mani et al.
BIOMATERIALS (2007)
Plasma methods for the generation of chemically reactive surfaces for biomolecule immobilization and cell colonization - A review
Kim Shyong Siow et al.
PLASMA PROCESSES AND POLYMERS (2006)
Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions
Ricardo A. Costa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation
Bryan P. Yan et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2006)
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells
R Blindt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood
TG Chen et al.
CELL PROLIFERATION (2006)
Tissue factor in cardiovascular diseases -: Molecular mechanisms and clinical implications
J Steffel et al.
CIRCULATION (2006)
Hypersensitivity cases associated with drug-eluting coronary stents - A review of available cases from the research on adverse drug events and reports (RADAR) project
JR Nebeker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus
MC Chen et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Rapamycin, but not FK-506, increases endothelial tissue factor expression -: Implications for drug-eluting stent design
J Steffel et al.
CIRCULATION (2005)
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents
AV Finn et al.
CIRCULATION (2005)
Endothelial progenitor cell capture by stents coated with antibody against CD34 - The HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry
J Aoki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Drug-eluting stents for the treatment of in-stent restenosis A clinical review
Bryan P. Y. Yan et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2005)
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?
R Virmani et al.
CIRCULATION (2004)
Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro
M Butzal et al.
EXPERIMENTAL CELL RESEARCH (2004)
The NUGGET study: NIR ultra gold-gilded equivalency trial
N Reifart et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2004)
Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel
T Ooya et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries:: double-blind, randomised controlled trial (E-SIRIUS)
J Schofer et al.
LANCET (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Usefulness of a cobalt chromium coronary stent alloy
DJ Kereiakes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Probucol promotes functional reendothelialization in balloon-injured rabbit aortas
AK Lau et al.
CIRCULATION (2003)
PLGA/TPGS nanoparticles for controlled release of paclitaxel: Effects of the emulsifier and drug loading ratio
L Mu et al.
PHARMACEUTICAL RESEARCH (2003)
Six-month angiographic and 12-month clinical follow-up of multilink long (25 to 35 mm) stents for long coronary narrowings in patients with angina pectoris
JA Ormiston et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Morphological predictors of restenosis after coronary stenting in humans
A Farb et al.
CIRCULATION (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure
D Antoniucci et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2001)
Comparison of the heparin coated vs the uncoated Jostent® -: no influence on restenosis or clinical outcome
J Wöhrle et al.
EUROPEAN HEART JOURNAL (2001)
Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial
F Kiemeneij et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis
R Köster et al.
LANCET (2000)
Phosphorylcholine-based polymers and their use in the prevention of biofouling
AL Lewis
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
In vitro analyses of diamond-like carbon coated stents: Reduction of metal ion release, platelet activation, and thrombogenicity
K Gutensohn et al.
THROMBOSIS RESEARCH (2000)
Immediate and late clinical and angiographic outcomes after GFX coronary stenting: Is high-pressure balloon dilatation necessary?
SW Park et al.
CLINICAL CARDIOLOGY (2000)
Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries
DM Whelan et al.
HEART (2000)
Share Paper
